Paradigm Shift in the Management of Infantile Hemangiomas in the Beta-blocker Era: A Retrospective Cohort Study

IF 12.8 1区医学 Q1 DERMATOLOGY

Journal of the American Academy of Dermatology Pub Date : 2025-07-12 DOI:10.1016/j.jaad.2025.07.017

Esteban Fernández Faith MD, Sonal D. Shah MD, Mitchell Braun MD, Elena Pope MD, Irene Lara-Corrales MD, Patricia M. Witman MD, Katya Harfmann MD, Flora Bradley MD, Jason Benedict MS, Alexandra Hallagan MD, Ilona J. Frieden MD

引用次数: 0

Abstract

Observation had been widely recommended for most patients with infantile hemangiomas (IH), although this approach predates the emergence of beta blockers for IH.

查看原文本刊更多论文

乙型受体阻滞剂时代婴儿血管瘤治疗的模式转变：一项回顾性队列研究

观察已被广泛推荐用于大多数婴儿血管瘤（IH）患者，尽管这种方法早于IH受体阻滞剂的出现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the American Academy of Dermatology 医学-皮肤病学

CiteScore

8.60

自引率

5.80%

发文量

2023

审稿时长

49 days

期刊介绍： The Journal of the American Academy of Dermatology (JAAD) is the official scientific publication of the American Academy of Dermatology (AAD). Its primary goal is to cater to the educational requirements of the dermatology community. Being the top journal in the field, JAAD publishes original articles that have undergone peer review. These articles primarily focus on clinical, investigative, and population-based studies related to dermatology. Another key area of emphasis is research on healthcare delivery and quality of care. JAAD also highlights high-quality, cost-effective, and innovative treatments within the field. In addition to this, the journal covers new diagnostic techniques and various other topics relevant to the prevention, diagnosis, and treatment of skin, hair, and nail disorders.